Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

317 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy and safety of maribavir dosed at 100 mg orally twice daily for the prevention of cytomegalovirus disease in liver transplant recipients: a randomized, double-blind, multicenter controlled trial.
Winston DJ, Saliba F, Blumberg E, Abouljoud M, Garcia-Diaz JB, Goss JA, Clough L, Avery R, Limaye AP, Ericzon BG, Navasa M, Troisi RI, Chen H, Villano SA, Uknis ME; 1263-301 Clinical Study Group. Winston DJ, et al. Among authors: navasa m. Am J Transplant. 2012 Nov;12(11):3021-30. doi: 10.1111/j.1600-6143.2012.04231.x. Epub 2012 Sep 4. Am J Transplant. 2012. PMID: 22947426 Free article. Clinical Trial.
ATG-Fresenius treatment and low-dose tacrolimus: results of a randomized controlled trial in liver transplantation.
Benítez CE, Puig-Pey I, López M, Martínez-Llordella M, Lozano JJ, Bohne F, Londoño MC, García-Valdecasas JC, Bruguera M, Navasa M, Rimola A, Sánchez-Fueyo A. Benítez CE, et al. Among authors: navasa m. Am J Transplant. 2010 Oct;10(10):2296-304. doi: 10.1111/j.1600-6143.2010.03164.x. Am J Transplant. 2010. PMID: 20883560 Free article. Clinical Trial.
Mannose-Binding Lectin-Deficient Donors Increase the Risk of Bacterial Infection and Bacterial Infection-Related Mortality After Liver Transplantation.
Lombardo-Quezada J, Sanclemente G, Colmenero J, Español-Rego M, Arias MT, Ruiz P, Mauro E, Sastre L, Crespo G, Rimola A, Moreno A, Lozano F, Navasa M. Lombardo-Quezada J, et al. Among authors: navasa m. Am J Transplant. 2018 Jan;18(1):197-206. doi: 10.1111/ajt.14408. Epub 2017 Aug 14. Am J Transplant. 2018. PMID: 28649744 Free article.
Influence of cytomegalovirus disease in outcome of solid organ transplant patients.
Linares L, Sanclemente G, Cervera C, Hoyo I, Cofán F, Ricart MJ, Pérez-Villa F, Navasa M, Marcos MA, Antón A, Pumarola T, Moreno A. Linares L, et al. Among authors: navasa m. Transplant Proc. 2011 Jul-Aug;43(6):2145-8. doi: 10.1016/j.transproceed.2011.05.007. Transplant Proc. 2011. PMID: 21839217
Immunohistochemically proven cytomegalovirus end-organ disease in solid organ transplant patients: clinical features and usefulness of conventional diagnostic tests.
Fica A, Cervera C, Pérez N, Marcos MA, Ramírez J, Linares L, Soto G, Navasa M, Cofan F, Ricart MJ, Pérez-Villa F, Pumarola T, Moreno A. Fica A, et al. Among authors: navasa m. Transpl Infect Dis. 2007 Sep;9(3):203-10. doi: 10.1111/j.1399-3062.2007.00220.x. Epub 2007 May 19. Transpl Infect Dis. 2007. PMID: 17511827
Epidemiology and risk factors for late infection in solid organ transplant recipients.
Cervera C, Fernández-Ruiz M, Valledor A, Linares L, Antón A, Ángeles Marcos M, Sanclemente G, Hoyo I, Cofán F, Ricart MJ, Pérez-Villa F, Navasa M, Pumarola T, Moreno A. Cervera C, et al. Among authors: navasa m. Transpl Infect Dis. 2011 Dec;13(6):598-607. doi: 10.1111/j.1399-3062.2011.00646.x. Epub 2011 Apr 27. Transpl Infect Dis. 2011. PMID: 21535336
317 results